NV Therapeutics
Berkeley, US · Founded 2024 · Delaware corporation · 1 known investors
Founders & leadership
AK
Audrey KozlovDirector
DD
Daniel DeverDirector
KH
Kevin HoldenExecutive Officer, Director, Promoter
DK
Dmitry KuzminDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$3MraisedMar 2025 · 1 investors · OtherRule 506(b)
▶$3MraisedMar 2025 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Audrey KozlovDirector
- Daniel DeverDirector
- Kevin HoldenExecutive Officer, Director, Promoter
- Dmitry KuzminDirector
- Offering amount
- $7.5M
- Amount sold
- $3M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.